TABLE 4.
Patient Survival by p16 IHC Status
5 y Overall Survival (%) | 5 y Disease-free Survival (%) | 5 y Disease-specific Survival (%) | |
---|---|---|---|
p16+* | 52 | 58 | 80 |
p16− | 54 | 48 | 73 |
p16+, >50% of tumor cells with nuclear and cytoplasmic staining; p16−, no tumor cell staining or <50% of tumor cells with staining.